Status:

COMPLETED

Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA)

Lead Sponsor:

The HIV Netherlands Australia Thailand Research Collaboration

Collaborating Sponsors:

Kirby Institute

National Health Security Office, Thailand

Conditions:

HIV Infections

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

This study will compare the efficacy and safety of ATV/r at either 200/100 mg or 300/100mg given daily in Thai patients in combination with 2NRTIs.

Detailed Description

To demonstrate non-inferiority of treatment with atazanavir/ritonavir (ATV/r) 200/100 mg once daily (OD) compared to the control group (ATV/r 300/100 mg OD) in regards to the proportion of virologic r...

Eligibility Criteria

Inclusion

  • HIV infected adults aged more than or equal to 18 years
  • Received ritonavir boosted PI-based HAART for \>3 months prior screening visit
  • History of HIV RNA \< 50 copies/ml within 12 months prior to screening visit
  • HIV-RNA \< 50 copies/ml at screening visit
  • Signed written informed consent

Exclusion

  • Active AIDS-defining disease or active opportunistic infection
  • History of virological failure (plasma HIV-RNA ≥1,000 copies/ml) while using any ritonavir boosted PI-based HAART
  • Pregnancy or lactation at screening visit
  • Relevant history or current conditions or illnesses that might interfere with drug absorption, distribution, metabolism or excretion e.g. chronic diarrhea, malabsorption
  • Use of concomitant medication that may interfere with the pharmacokinetics of the study drugs e.g. rifampicin, proton pump inhibitor
  • History of sensitivity/idiosyncrasy to the drug or chemically related compounds which may be employed in the study
  • ALT ≥200 IU/L at screening visit
  • Creatinine clearance \< 60 c.c. per min by Cockroft-Gault formula at screening visit

Key Trial Info

Start Date :

May 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2015

Estimated Enrollment :

559 Patients enrolled

Trial Details

Trial ID

NCT01159223

Start Date

May 1 2011

End Date

June 1 2015

Last Update

August 18 2016

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

Chiang Rai Regional Hospital

Chiang Rai, Changwat Chiang Rai, Thailand

2

ChonBuri Hospital

Chon Buri, Changwat Chon Buri, Thailand

3

Khon Kaen University

Khon Kaen, Changwat Khon Kaen, Thailand

4

Bamrasnaradura Infectious Diseases Institute

Nonthaburi, Changwat Nonthaburi, Thailand, 11000

Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA) | DecenTrialz